BCM
EXAS

Bayesian Capital Management’s Exact Sciences EXAS Stock Holding History

Bayesian Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,922
Closed -$601K – 168
2025
Q4 		$601K Buy
+5,922
New +$476K 1.38% 20
2025
Q2 		– Sell
-23,013
Closed -$996K – 647
2025
Q1 		$996K Buy
+23,013
New +$1.17M 0.16% 170
2024
Q4 		– Sell
-4,723
Closed -$322K – 779
2024
Q3 		$322K Buy
+4,723
New +$267K 0.04% 462
2024
Q2 		– Sell
-23,120
Closed -$1.6M – 852
2024
Q1 		$1.6M Buy
23,120
+1,900
+9% +$120K 0.15% 191
2023
Q4 		$1.57M Buy
21,220
+16,202
+323% +$1.06M 0.17% 157
2023
Q3 		$342K Sell
5,018
-15,900
-76% -$1.35M 0.04% 440
2023
Q2 		$1.96M Buy
+20,918
New +$1.63M 0.21% 130
2023
Q1 		– Sell
-19,025
Closed -$942K – 890
2022
Q4 		$942K Buy
19,025
+2,225
+13% +$90.9K 0.14% 197
2022
Q3 		$546K Buy
+16,800
New +$693K 0.11% 259
2021
Q4 		– Sell
-5,700
Closed -$544K – 427
2021
Q3 		$544K Buy
+5,700
New +$602K 0.16% 177
2019
Q4 		– Sell
-8,100
Closed -$732K – 643
2019
Q3 		$732K Buy
+8,100
New +$923K 0.14% 206
2019
Q2 		– Sell
-15,400
Closed -$1.33M – 555
2019
Q1 		$1.33M Buy
+15,400
New +$1.31M 0.26% 118
2018
Q3 		– Sell
-5,457
Closed -$326K – 677
2018
Q2 		$326K Buy
+5,457
New +$294K 0.07% 371
2018
Q1 		– Sell
-15,500
Closed -$814K – 649
2017
Q4 		$814K Buy
15,500
+6,000
+63% +$320K 0.17% 213
2017
Q3 		$448K Buy
9,500
+600
+7% +$24.2K 0.11% 289
2017
Q2 		$315K Sell
8,900
-12,400
-58% -$383K 0.12% 277
2017
Q1 		$503K Buy
+21,300
New +$422K 0.24% 158
2016
Q4 		– Sell
-18,600
Closed -$345K – 625
2016
Q3 		$345K Buy
+18,600
New +$328K 0.23% 166
2016
Q1 		– Sell
-10,200
Closed -$94K – 376
2015
Q4 		$94K Buy
+10,200
New +$94.8K 0.13% 215

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Bayesian Capital Management's EXAS Position: Q1 2026 in Review

Bayesian Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,922 shares — an estimated $601K sold.

Bayesian Capital Management first reported a position in EXAS in Q4 2015 and held it in 19 quarters. The position peaked at $1.96M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bayesian Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 5,922 Exact Sciences shares in Q1 2026, an estimated $601K.
  • Bayesian Capital Management first reported a position in Exact Sciences in Q4 2015 and held it in 19 quarters.
  • Bayesian Capital Management's Exact Sciences position peaked at $1.96M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.